4 days ago

Condition: Prostate Cancer Interventions: Drug: metformin hydrochloride; Other: placebo Sponsors: University of Arizona; National Cancer Institute (NCI) Recruiting – verified February 2012 Read more from the original source: Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoin ...

4 days ago

Condition: Nasopharyngeal Neoplasms Interventions: Drug: gemcitabine and cisplatin; Drug: cisplatin and 5-Fluorouracil Sponsor: Sun Yat-sen University Recruiting – verified February 2012 See the rest here: GP Versus PF in the Treatment of Advanced Nasopharyngeal Carcinoma (NPC)

17 days ago

Condition: Colorectal Cancer Interventions: Behavioral: Stage 1; Behavioral: Stage 2 Sponsors: Philadelphia Veterans Affairs Medical Center; VA Pittsburgh Healthcare System Not yet recruiting – verified January 2012 The rest is here: Improving Fecal Occult Blood Test Completion Rates Among Veterans

17 days ago

Conditions: Chemotherapy-induced Neutropenia; Breast Cancer Interventions: Drug: LA-EP2006; Drug: Peg-Filgrastim Sponsor: Sandoz Recruiting – verified January 2012 Read the original here: Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

17 days ago

Conditions: Secondary Malignant Neoplasm of Liver; Colorectal Neoplasms Interventions: Procedure: Open liver resection; Procedure: Laparoscopic liver resection Sponsors: Oslo University Hospital; Helse Sor-Ost Not yet recruiting – verified January 2012 See the original post here: Oslo Randomized Lap ...

17 days ago

Condition: Actinic Keratosis Interventions: Drug: Vehicle gel; Drug: SR-T100 with 1.0% of SM; Drug: SR-T100 with 2.3% of SM Sponsor: G&E Herbal Biotechnology Co., LTD Not yet recruiting – verified January 2012 See original here: Efficacy and Safety Phase II Dose-ranging Study of SR-T100 to Treat Act ...

19 days ago

Conditions: Advanced Cancers; Dyspnea Interventions: Drug: Fentanyl; Other: Placebo; Other: Walking Tests; Behavioral: Questionnaires Sponsor: M.D. Anderson Cancer Center Not yet recruiting – verified January 2012 Go here to read the rest: Breakthrough Dyspnea Fentanyl Study

19 days ago

Condition: Leukemia Interventions: Drug: Cladribine; Drug: Cytarabine; Drug: Decitabine Sponsor: M.D. Anderson Cancer Center Not yet recruiting – verified January 2012 Read this article: Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (A ...

19 days ago

Condition: Gastric Cancer Interventions: Drug: DOCETAXEL (XRP6976); Drug: OXALIPLATIN (SR96669); Drug: S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + CDHP (Gemeracil) + Oxo (Oteracil) Sponsor: Sanofi-Aventis Not yet recruiting – verified January 2012 Read more here: Docetaxel+Oxaliplatin+S-1 (DOS) Regi ...

19 days ago

Condition: Melanoma Interventions: Biological: Ipilimumab; Biological: Ipilimumab Sponsor: Bristol-Myers Squibb Not yet recruiting – verified January 2012 Read the rest here: Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab